ACAD vs GILD: Which Stock is Better?
Side-by-side comparison of Acadia Pharmaceuticals Inc and Gilead Sciences Inc in 2026
ACAD
Acadia Pharmaceuticals Inc
$26.29
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | ACAD | GILD | Winner |
|---|---|---|---|
| Market Cap | $4.45B | $154.99B | GILD |
| P/E Ratio | 16.96 | 19.34 | ACAD |
| EPS (TTM) | $1.55 | $6.46 | GILD |
| Revenue Growth | 0.1% | 0.0% | ACAD |
| Gross Margin | 59.0% | 78.7% | GILD |
Analyze ACAD
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACAD or GILD a better investment?
Comparing ACAD and GILD: Acadia Pharmaceuticals Inc has a market cap of $4.45B while Gilead Sciences Inc has $154.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACAD and GILD?
ACAD (Acadia Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACAD or GILD?
Based on P/E ratios, ACAD trades at a lower multiple (17.0x vs 19.3x).
Which is growing faster: ACAD or GILD?
ACAD has higher revenue growth at 0.1% vs 0.0% for GILD.
Which company is more profitable: ACAD or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to 59.0% for ACAD.
Which is the larger company: ACAD or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.99B compared to $4.45B for ACAD.
Should I buy ACAD or GILD in 2026?
Both ACAD and GILD have investment merit. ACAD trades at $26.29 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACAD and GILD stock?
Key differences: Market Cap ($4.45B vs $154.99B), P/E Ratio (17.0x vs 19.3x), Revenue Growth (0.1% vs 0.0%), Gross Margin (59.0% vs 78.7%).